Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Washington University School of Medicine
Related studies linked through entity extraction aliases.
Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Virtual Senior Center
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
- Status
- RECRUITING
- Phase
- NA
Diabetes Management for Primary Healthcare Centers.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Status
- COMPLETED
- Phase
- N/A
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
- Status
- RECRUITING
- Phase
- N/A
Precision Imaging to Evaluate Kaposi Sarcoma
- Status
- RECRUITING
- Phase
- NA
Role of KATP Channel Loss in Type 2 Diabetes
- Status
- RECRUITING
- Phase
- NA
Implement and Test Visual Consent Template and Process
- Status
- TERMINATED
- Phase
- NA
Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia
- Status
- COMPLETED
- Phase
- N/A
Auricular VNS Following Intracerebral Hemorrhage
- Status
- RECRUITING
- Phase
- NA
Endometriosis and Migraine
- Status
- RECRUITING
- Phase
- N/A
Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Light Therapy for Obsessive-compulsive Disorder (OCD)
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
The Minimalist Trial-2
- Status
- RECRUITING
- Phase
- PHASE2
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- Status
- RECRUITING
- Phase
- NA
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2